Skip to content
healthcare.dev

Bumetanide

NDC 16571-679, bumetanide, tablet, from Rising Pharma Holdings, Inc.

Product NDC
16571-679
Status
Listed
Labeler
Rising Pharma Holdings, Inc
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212019
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-679 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUMETANIDE.5 mg/1

Pharmacologic classes

Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]

Package NDCNDC-11Package
16571-679-0116571067901100 TABLET in 1 BOTTLE (16571-679-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/627c9732-eed1-4435-8d79-2e19ab974fd9
  • NADAC price for package 16571067901

    GET /v1/drugs/nadac/16571067901

Use it

Look up 16571-679 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-679 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-679. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.